Interestingly, hyperglycemia-induced miR-22 promotes EMT by suppressing autophagy via targeting phosphatase and tensin homolog/protein kinase B (Akt)/mTOR signaling pathway, which suggests that targeting miRNA may be a promising therapeutic approach in preventing DN (32). Here, MTOR is linked to liver dysplastic nodule.